Related references
Note: Only part of the references are listed.Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre
Bedeir Ali-El-Dein et al.
BJU INTERNATIONAL (2013)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guerin, and Bacillus Calmette-Guerin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
Richard J. Sylvester et al.
EUROPEAN UROLOGY (2010)
Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy
Ioannis Zachos et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model
Jesus Fernandez-Gomez et al.
JOURNAL OF UROLOGY (2009)
Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion
Cheryl T. Lee et al.
UROLOGY (2007)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Initial high-grade T1 urothelial cell carcinoma:: Feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients
A Orsola et al.
EUROPEAN UROLOGY (2005)
Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guerin with a reduced dose of 27 mg in superficial bladder cancer
JA Martínez-Piñeiro et al.
BJU INTERNATIONAL (2002)
Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
HW Herr et al.
JOURNAL OF UROLOGY (2001)
The predictive value of muscularis mucosae invasion and p53 over expression on progression of stage T1 bladder carcinoma
S Bernardini et al.
JOURNAL OF UROLOGY (2001)
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations
T Lebret et al.
JOURNAL OF UROLOGY (2000)
Share Paper
